Why cannabis has stricter labels than alcohol globally

This research paper examines labelling requirements for alcohol, tobacco, and cannabis across 194 WHO Member States, revealing a striking regulatory disparity. While 84.5% of countries mandate health warnings on tobacco and all jurisdictions with legal recreational cannabis require multiple labelling measures including health warnings and ingredient information, only 32.5% of WHO Member States mandate warnings on alcohol—despite alcohol being a leading cause of global death and disability. Canada exemplifies this inconsistency, as alcohol remains the only controlled substance without federally mandated warning labels in the country, while tobacco and cannabis products face rigorous government-mandated labelling requirements.

The study highlights that cannabis products are subject to particularly comprehensive labelling standards that include health warnings, ingredient disclosure, allergen information, calorie content, and additive listings. This regulatory framework for cannabis demonstrates that governments can and do implement robust labelling systems for controlled substances. The researchers argue that strengthening alcohol labelling requirements could support informed decision-making and reduce substance-related harms, with high population reach through a relatively straightforward policy intervention. The findings suggest that Canada's current regulatory approach underestimates the public health burden of alcohol compared to other controlled substances.

The paper's broader implication is that establishing evidence-based minimum international standards for alcohol labelling could strengthen global regulatory coherence. By comparing cannabis, tobacco, and alcohol regulations side-by-side, the research demonstrates that more stringent labelling protections are feasible and already implemented for cannabis in legal jurisdictions, making the case that similar standards should be applied to alcohol given its significantly higher documented health impact.